# Jasper Therapeutics, Inc.: Form SC 13D/A, filed Feb 9, 2024

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: SC 13D/A
- Filed: 2024-02-09
- Accepted by EDGAR: Feb 9, 2024, 20:36 ET
- Period: not reported
- Accession: 0000921895-24-000336
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000092189524000336/sc13da112927020_02092024.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000092189524000336/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000092189524000336/sc13da112927020_02092024.htm

Filed Feb 9, 2024.
Source: SEC EDGAR, the filing index for accession 0000921895-24-000336. Last ingested by Listed: Nov 9, 2026, 17:50 ET. No prices; not investment advice.